Details for New Drug Application (NDA): 061164
✉ Email this page to a colleague
NDA 061164 describes VEETIDS '500', which is a drug marketed by Apothecon and is included in two NDAs. Additional details are available on the VEETIDS '500' profile page.
The generic ingredient in VEETIDS '500' is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
The generic ingredient in VEETIDS '500' is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for 061164
| Tradename: | VEETIDS '500' |
| Applicant: | Apothecon |
| Ingredient: | penicillin v potassium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
